AdaptHealth (AHCO) 2026 Jefferies Healthcare Services and Technology Conference summary

Leadership and organizational transformation

• New CFO brings extensive public company experience and aims to drive the next phase of growth.

• Leadership team has been strengthened over the past two years, with new talent making a measurable impact.

• Company has transitioned from a holding company of 160+ acquisitions to a unified national player focused on scale.

• Strategic focus is on building a dominant presence in high-population geographies and payer networks.

• Industry consolidation is benefiting larger, national providers with scale and expertise.

Portfolio optimization and strategic divestitures

• Portfolio has been streamlined to focus on sleep, respiratory, and home medical equipment.

• Diabetes segment divestiture will be completed in the first half of next year, with proceeds allocated to debt reduction.

• Post-divestiture, growth investments will target sleep and respiratory markets, leveraging favorable trends.

• Stranded costs from the divestiture are being addressed through operational growth, restructuring, and technology investments.

Growth drivers and operational initiatives

• Capitated contracts with major payers like Humana and Kaiser Permanente are driving significant organic growth.

• National expansion included opening 40 new locations in California, supporting exclusive patient volume.

• Growth strategy centers on maximizing patient acquisition and utilization of existing locations.

• Direct-to-consumer joint venture and e-commerce initiatives are expanding patient access to sleep therapies.